Protocol № 069-P
V1.0
Updated JULY 2026
Tesamorelin protocol
A practitioner operating manual for running Tesamorelin – what to buy, how to dose and titrate, what to watch for. Mechanism: 12.1 Mechanism of Action In vitro, tesamorelin binds and stimulates human GRF receptors with similar potency as the endogenous GRF [see Clinical Pharmacology ( 12.2 )]. Growth hormone-releasing factor
At a glance
Ready to run
Route
Subcutaneous
Frequency
Daily
Cycle
26 weeks
Est. cost
$300-600/month
First signal
2-4 weeks
NO AFFILIATE LINKS
Member access
The full protocol is for members only
Complete dosing guides, titration schedules, supply lists and clinical monitoring protocols are available exclusively to verified Method members.
Our membership if Free for all community members